Updates are available New version dated 2023-09-25

Click to view New version: https://doi.org/10.29328/journal.jprr.1001047

Clinical Approach to Immunotherapy-induced Type 1 Diabetes Mellitus: A Case of Pembrolizumab Associated Insulin-dependent Diabetes in a Patient with NSCLC

Crossref DOI link: https://doi.org/10.29328/journal.jprr.1001047

Published Online: 2023-09-25

Published Print: 2023-09-25

Update policy: https://doi.org/10.29328/crossmark-policy

About CrossMark